Discovery and Preclinical Pharmacology of INE963, a Potent and Fast-Acting Blood-Stage Antimalarial with a High Barrier to Resistance and Potential for Single-Dose Cures in Uncomplicated Malaria
Benjamin R. Taft(Novartis (United States)), Christopher R. Sarko(Novartis (United States)), Judith Straimer(Novartis (United States)), Wei Shu(Novartis (United States)), H. D. Schulz(Humboldt-Universität zu Berlin), Brice Campo(Medicines for Malaria Venture), Siti Nurdiana Abas(Novartis (Singapore)), Marı́a Belén Jiménez-Dı́az(Euskadiko Parke Teknologikoa), Íñigo Angulo‐Barturen(Euskadiko Parke Teknologikoa), Armand Guiguemde, Jafri Qumber, Christophe Bodenreider(Novartis (Singapore)), Fumiaki Yokokawa(Novartis (United States)), Suresh B. Lakshminarayana, Xiaoman Ang(Novartis (Singapore)), Jessie Lim(Novartis (Singapore)), Benigno Crespo-Fernández(GlaxoSmithKline (France)), Nicole Blaquière(Novartis (United States)), Richard S.P. Huang(TGS (United Kingdom)), Tom Kirrane(Novartis (United States)), Christian Lanshoeft(Novartis (Switzerland)), Thierry T. Diagana(NovaBay Pharmaceuticals (United States)), Christopher Thompson, Anne-Catherine Mata(Novartis (United States)), Wai Ling Chan(Novartis (Singapore)), Subramanyam Vankadara(Novartis (Singapore)), Anna Caroline Campos Aguiar(Universidade Federal de Minas Gerais), Yen‐Liang Chen(NovaBay Pharmaceuticals (United States)), Sandra Phek Lin Sim(Novartis (Singapore)), Eric Fang(University of Illinois Urbana-Champaign), Philip J. Rosenthal(University of California, San Francisco), Patrick K. Tumwebaze(Infectious Diseases Research Collaboration), Luying Pei, Oliver Simon(Novartis (Singapore)), Mei Ding(Novartis (Singapore)), Yugang Liu(Northwestern University), Bin Zou(Janssen (United States)), Katherine Chan, Simon F. Campbell(Medicines for Malaria Venture), Jürgen Wagner(Vogtland-Klinik), Jay Prakash Jain, Roland A. Cooper(Dominican University of California), Grace M. Waldron(Novartis (United States)), Francisco‐Javier Gamo(GlaxoSmithKline (France))
Cited by 32
Related Papers
Effect of Service Transition Strategies on Firm Value
|Journal of Marketing|2008|573
Effect of Service Transition Strategies on Firm Value
|Journal of Marketing|2008|486
Efficient Aldolase Catalytic Antibodies That Use the Enamine Mechanism of Natural Enzymes
|Science|1995|458
Influence of customer participation on creating and sharing of new product value
|Journal of the Academy of Marketing Science|2008|407